Mg0011 22 — Chapel Hill, North Carolina

Mg0011 22 is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mg0011 22 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Generalized Myasthenia Gravis.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mg0011 22?

Mg0011 22 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mg0011 22 conducted?

Mg0011 22 has 1 clinical trials on record, with 1 currently active. Their work covers Generalized Myasthenia Gravis.

Is Mg0011 22 accredited by Crixeo Health?

Mg0011 22 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mg0011 22?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.